The Asia Pacific Wound Management Devices Market would witness market growth of 8.5% CAGR during the forecast period (2020-2026).
Patients around the world are looking for fast and cost-effective treatment of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Whereas, active wound care products, comprising biological skin equivalents, growth factors have an organized and clinically proven efficiency to treat critical chronic wounds.
As of now, there are a bunch of companies working in this section, and these companies are concentrating on introducing new bioactive products in the market. Thus, the introduction of advanced active therapies by domestic market players have been instrumental in boosting the adoption of skin grafts, collagen dressings, and other active therapies, which, in turn, boosting the selection of skin joins collagen dressings, and other dynamic treatments, which will help the worldwide market during the forecast period.
Expanding interest for anti-infective dressings, for example, plant-based sterile dressings and iodine-based dressings for the treatment of chronic injuries and related skin ulcers is trending in the market. The anti-infective dressings are sub-portion of traditional injury dressings. The wound care products that are formed from plant materials are films, hydro fiber, hydrocolloids, collagen, alginates, and foams. These products hold anti-microbial properties that produce less irritation on the skin and hence shorten the healing time compared to basic wound care products.
Based on Product, the market is segmented into Therapy Devices, Wound closure Devices and Other Products. Based on Application, the market is segmented into Burns, Pressure Ulcers, Diabetic Foot Ulcers, Surgical Wounds and Other Applications. Based on End User, the market is segmented into Clinics, Hospitals and Other End User. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Coloplast Group, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.), Johnson and Johnson, 3M Company, Medtronic PLC, Smith & Nephew PLC, Hollister, Inc., and Molnlycke Health Care AB.
Scope of the Study
Market Segmentation:
By Product

  • Therapy Devices
  • Wound closure Devices and
  • Other Products


By Application

  • Burns
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Surgical Wounds and
  • Other Applications


By End User

  • Clinics
  • Hospitals and
  • Other End User


By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific


Companies Profiled

  • Baxter International, Inc.
  • Coloplast Group
  • ConvaTec Group PLC
  • Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.)
  • Johnson and Johnson
  • 3M Company
  • Medtronic PLC
  • Smith & Nephew PLC
  • Hollister, Inc.
  • Molnlycke Health Care AB


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free